Skip to main content

Table 2 Infusion rate and administration period of investigational drug

From: Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of Japanese patients in the intensive care unit: a double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study

 

Remifentanil

N = 92

Fentanyl

N = 90

Infusion rate-mean 

   Remifentanil: µg/kg/min

   Fentanyl: µg/kg/h

0.046 ± 0.036

(0.02, 0.24)

0.215 ± 0.191

(0.10, 1.17)

Infusion rate-minimum

   Remifentanil: µg/kg/min

   Fentanyl: µg/kg/h

0.024 ± 0.002

(0.01, 0.025)

0.100 ± 0.001

(0.09, 0.10)

Infusion rate-maximum

   Remifentanil: µg/kg/min

   Fentanyl: µg/kg/h

0.056 ± 0.054

(0.025, 0.34)

0.321 ± 0.644

(0.10, 6.00)

Dosing duration (h)

12.37 ± 14.58

(6.0, 119.5)

12.59 ± 16.26

(3.6, 121.9)

  1. Data are shown as Mean ± SD (Min, Max)